Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
09 Dec 2019
Historique:
received: 27 08 2019
accepted: 21 11 2019
entrez: 11 12 2019
pubmed: 11 12 2019
medline: 10 5 2020
Statut: epublish

Résumé

The clinical value of the controlling nutritional status (CONUT) score in hepatocellular carcinoma (HCC) has increased. The aim of this meta-analysis was to systematically review the association between the CONUT score and outcomes in patients undergoing hepatectomy for HCC. Embase, Medline Ovid, Web of Science, Cochrane CENTRAL, and Google Scholar were systematically searched. Random effects meta-analyses were conducted to examine the prognostic value of the CONUT score in HCC patients. A total of five studies including 4679 patients were found to be eligible and analyzed in the meta-analysis. The CONUT score was significantly associated with overall survival (HR 1.78, 95%CI = 1.20-2.64, P = 0.004, I The CONUT score is an independent prognostic indicator of the prognosis and is associated with postoperative major complications and hepatic functional reserve in HCC patients.

Sections du résumé

BACKGROUND BACKGROUND
The clinical value of the controlling nutritional status (CONUT) score in hepatocellular carcinoma (HCC) has increased. The aim of this meta-analysis was to systematically review the association between the CONUT score and outcomes in patients undergoing hepatectomy for HCC.
METHODS METHODS
Embase, Medline Ovid, Web of Science, Cochrane CENTRAL, and Google Scholar were systematically searched. Random effects meta-analyses were conducted to examine the prognostic value of the CONUT score in HCC patients.
RESULTS RESULTS
A total of five studies including 4679 patients were found to be eligible and analyzed in the meta-analysis. The CONUT score was significantly associated with overall survival (HR 1.78, 95%CI = 1.20-2.64, P = 0.004, I
CONCLUSIONS CONCLUSIONS
The CONUT score is an independent prognostic indicator of the prognosis and is associated with postoperative major complications and hepatic functional reserve in HCC patients.

Identifiants

pubmed: 31818259
doi: 10.1186/s12876-019-1126-6
pii: 10.1186/s12876-019-1126-6
pmc: PMC6902571
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

211

Références

J Clin Oncol. 2010 Jun 10;28(17):2889-95
pubmed: 20458042
World J Surg. 2017 Nov;41(11):2805-2812
pubmed: 28653142
Lancet. 2012 Mar 31;379(9822):1245-55
pubmed: 22353262
Int J Surg. 2018 Jul;55:39-45
pubmed: 29783000
HPB (Oxford). 2018 Oct;20(10):888-895
pubmed: 29853431
J Am Coll Surg. 2014 Mar;218(3):412-22
pubmed: 24468222
Chin Med J (Engl). 2016 Mar 5;129(5):536-41
pubmed: 26904987
Oncotarget. 2016 Apr 19;7(16):22948-59
pubmed: 27027345
Semin Liver Dis. 1999;19(3):329-38
pubmed: 10518312
Ann Nutr Metab. 2019;74(4):303-312
pubmed: 31013491
Clin Cancer Res. 2014 Dec 1;20(23):6212-22
pubmed: 25271081
PLoS One. 2018 Oct 12;13(10):e0202987
pubmed: 30312295
World J Surg. 2015 Jun;39(6):1501-9
pubmed: 25670038
J Cancer Res Clin Oncol. 2014 Sep;140(9):1537-49
pubmed: 24878931
Br J Surg. 2015 Nov;102(12):1448-58
pubmed: 26375617
Sci Rep. 2018 Sep 7;8(1):13406
pubmed: 30194336
Eur J Surg Oncol. 2019 May;45(5):782-787
pubmed: 30503048
Nutr Hosp. 2005 Jan-Feb;20(1):38-45
pubmed: 15762418
World J Surg. 2017 Sep;41(9):2353-2360
pubmed: 28389736
Ann Surg. 2018 Jul;268(1):58-69
pubmed: 29373365
Ann Surg Oncol. 2018 Oct;25(11):3316-3323
pubmed: 30051372
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Clin Transl Oncol. 2019 Jun 14;:null
pubmed: 31201606
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Dig Surg. 2019;36(3):226-232
pubmed: 29672297
Clin Chim Acta. 2017 Nov;474:155-158
pubmed: 28964833
Int J Cancer. 2013 Mar 1;132(5):1133-45
pubmed: 22752881

Auteurs

Kosei Takagi (K)

Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands. kotakagi15@gmail.com.
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. kotakagi15@gmail.com.

Piotr Domagala (P)

Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.
Department of General and Transplantation Surgery, The Medical University of Warsaw, Warsaw, Poland.

Wojciech G Polak (WG)

Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.

Stefan Buettner (S)

Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.

Jan N M Ijzermans (JNM)

Department of Surgery, Erasmus MC, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH